Cialis has several common side effects, many of which also happen with other drugs used to treat ED, like sildenafil (generic Viagra®), vardenafil (Levitra), and avanafil (Stendra®).

Cialis is primarily for treating ED but can also treat an enlarged prostate. In addition, under the brand name Adcirca, tadalafil can also treat pulmonary arterial hypertension (PAH).

Cialis 5 mg for once daily use was approved by the U.S. Food and Drug Administration (FDA) in October 2011 for the treatment of the signs and symptoms of BPH. The FDA also approved Cialis 5 mg for ...

Keeping it very, tadalafil lasts for 36 cialis 10 generic and sometimes longer, and has the largest duration of action of all the PDE5 reaches. In addition, paleness of tadalafil is not affected by ...

INDIANAPOLIS, Oct. 25, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved a product label addition for CIALIS to include ...

United Therapeutics Corp. announced Tuesday the approval of Adcirca (tadalafil) tablets, designed to improve exercise ability in WHO Group I PAH patients.

United Therapeutics Corp has received approval from regulators in the USA for tadalafil, the active ingredient in Eli Lilly’s erectile dysfunction drug Cialis, for the treatment of pulmonary arterial ...

May 27 -- TUESDAY, May 26 (HealthDay News) -- United Therapeutics has received approval from the U.S. Food and Drug Administration to market Adcirca (tadalafil) to treat pulmonary arterial ...

Daily use of tadalafil, a phosphodiesterase-5 inhibitor used to treat erectile dysfunction, did not result in improved erectile dysfunction for men who underwent radiotherapy for prostate cancer ...

Mylan announced the launch of Tadalafil Tablets, the first generic version of Eli Lilly‘s Adcirca. Tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, is indicated to treat pulmonary arterial ...